single doses of p38 map kinase inhibitors or prednisolone affect crp and il-6 in patients with active rheumatoid arthritis (ra)单剂量的地图p38激酶抑制剂或强的松影响c反应蛋白和il - 6活性类风湿性关节炎(ra)患者.pdfVIP

下载本文档

2
0
约9.37万字
约 13页
2017-08-29 发布于上海
举报

single doses of p38 map kinase inhibitors or prednisolone affect crp and il-6 in patients with active rheumatoid arthritis (ra)单剂量的地图p38激酶抑制剂或强的松影响c反应蛋白和il - 6活性类风湿性关节炎(ra)患者.pdf

single doses of p38 map kinase inhibitors or prednisolone affect crp and il-6 in patients with active rheumatoid arthritis (ra)单剂量的地图p38激酶抑制剂或强的松影响c反应蛋白和il - 6活性类风湿性关节炎(ra)患者

Vol.2, No.3, 85-97 (2012) Open Journal of Immunology /10.4236/oji.2012.23011 Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA) * Pauline T. Lukey , Hayley C. Perry, Shuying Yang, Simon Parry, Marion C. Dickson, Virginia H. Norris, Paul G. Russell, Marie Watissée, Inmaculada Rioja, Keith P. Ray, Scott Crowe, Michael Binks * GlaxoSmithKline RD, M

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

single doses of p38 map kinase inhibitors or prednisolone affect crp and il-6 in patients with active rheumatoid arthritis (ra)单剂量的地图p38激酶抑制剂或强的松影响c反应蛋白和il - 6活性类风湿性关节炎(ra)患者.pdfVIP